| Order in the matter of M/s. ABL Biotechnologies Ltd. |
To
All Trading Members of the Exchange
Sub: Order under Sections 11 and 11B of the Securities and Exchange Board of India Act, 1992 in the matter of M/s. ABL Biotechnologies Ltd.
SEBI, vide its Order no. WTM/SKM/EFD1-DRAI/02/2019-20 dated May 31, 2019 has issued the following directions:
- Restrained M/s. ABL Biotechnologies Ltd (PAN: AAACA5463G), the Company from accessing the Securities Market including by issuing prospectus, offer document or advertisement soliciting money from the public and is further prohibited from buying, selling or otherwise dealing in securities, directly or indirectly in any manner, from the date of this order till the expiry of five years from the date of bringing back the money in ABL’s bank account in terms of the aforesaid direction.
- Restrained Clifford Capital Partners A.G.S.A (PAN: Not Available) and Mr. Kollenmareth Oomman Isaac (PAN: AAAPI2428J) from accessing the Securities Market in India and further prohibited from buying, selling or otherwise dealing in securities of Indian Securities Market, directly or indirectly in any manner, for a period of five years from the date of this order.
- Rosemary Isaac, Mr. G Subramanian and Mr. Raveendran Sappany are warned and advised to be careful and act diligently while dealing in any manner in Securities Market.
- Further as directed in the aforesaid order, it is clarified that during the period of restraint, the existing holding of the Noticees namely ABL Biotechnologies Ltd, Clifford Capital Partners A.G.S.A and Mr. Kollenmareth Oomman Isaac including units of mutual funds, of the Noticees shall remain frozen.
This Order shall come into force with immediate effect.
A copy of the said Order is attached herewith and available on the SEBI website www.sebi.gov.in.
Trading members are advised to take note of the same and ensure compliance.
Shaila Valsan Avijit Sarkar
Manager Assistant Manager
Surveillance Surveillance
Date: May 31, 2019 |